Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 50 (16) , PL129-PL134
- https://doi.org/10.1016/0024-3205(92)90466-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophreniaBiological Psychiatry, 1991
- D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocainePsychopharmacology, 1990
- Sigma receptors regulate contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotoninJournal of Neuroscience, 1989
- Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitizationPsychopharmacology, 1989
- Novel antipsychotic drugs share high affinity for σ receptorsEuropean Journal of Pharmacology, 1988
- Classification and nomenclature of phencyclidine and sigma receptor sitesTrends in Neurosciences, 1987
- Potential antipsychotic BMY 14802 selectively binds to sigma sitesDrug Development Research, 1987
- Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosisBrain Research Reviews, 1986
- BW234U,(cis-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agentJournal of Pharmacy and Pharmacology, 1982
- Evolving Behavior in the Clinical and Experimental Amphetamine (Model) PsychosisAmerican Journal of Psychiatry, 1973